Last updated: 20 June 2019 at 2:57am EST

Donagh Mccarthy Net Worth




The estimated Net Worth of Donagh Mccarthy is at least $14.2 Milion dollars as of 14 February 2007. Donagh Mccarthy owns over 32,000 units of Resmed stock worth over $14,163,520 and over the last 21 years Donagh sold RMD stock worth over $0.

Donagh Mccarthy RMD stock SEC Form 4 insiders trading

Donagh has made over 4 trades of the Resmed stock since 2003, according to the Form 4 filled with the SEC. Most recently Donagh exercised 32,000 units of RMD stock worth $272,000 on 14 February 2007.

The largest trade Donagh's ever made was exercising 32,000 units of Resmed stock on 14 February 2007 worth over $272,000. On average, Donagh trades about 7,667 units every 107 days since 2003. As of 14 February 2007 Donagh still owns at least 56,000 units of Resmed stock.

You can see the complete history of Donagh Mccarthy stock trades at the bottom of the page.



What's Donagh Mccarthy's mailing address?

Donagh's mailing address filed with the SEC is , , , , .

Insiders trading at Resmed

Over the last 22 years, insiders at Resmed have traded over $250,830,262 worth of Resmed stock and bought 10,000 units worth $424,500 . The most active insiders traders include Peter C Farrell, Gary W Pace a David Pendarvis. On average, Resmed executives and independent directors trade stock every 7 days with the average trade being worth of $3,005,701. The most recent stock trade was executed by Brett Sandercock on 9 September 2024, trading 1,000 units of RMD stock currently worth $246,420.



What does Resmed do?

at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.



Complete history of Donagh Mccarthy stock trades at Resmed

Osoba
Trans.
Transakce
Celková cena
Donagh Mccarthy
Ředitel
Využití opce $272,000
14 Feb 2007
Donagh Mccarthy
Ředitel
Využití opce $184,960
9 Feb 2006
Donagh Mccarthy
Ředitel
Využití opce $84,000
10 May 2005
Donagh Mccarthy
Ředitel
Využití opce $57,260
13 Aug 2003


Resmed executives and stock owners

Resmed executives and other stock owners filed with the SEC include: